Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Olivier Rixe"'
Autor:
El Mustapha Bahassi, Li Deng, Keith M. Wilson, Trisha Wise-Draper, Jiang Wang, Susanne I. Wells, Colleen N. Darnell, Olivier Rixe, Peter J. Stambrook, Ya-Qin Li
Publikováno v:
European Journal of Cancer. 49:2345-2355
Background Cetuximab is an epidermal growth factor receptor (EGFR)-blocking antibody that has been approved for the treatment of patients with head and neck squamous cell carcinoma (HNSCC) and metastatic colorectal cancer, but no predictive biomarker
Autor:
B. Billemont, Eric Van Cutsem, David Khayat, Karen Soussan-Lazard, Sylvaine Cartot-Cotton, Olivier Rixe, Sabine Tejpar, Jean-Baptiste Meric, Sylvie Assadourian, Chris Verslype
Publikováno v:
European Journal of Cancer. 49:17-24
Background To determine dose-limiting toxicities (DLTs), recommended phase II trial dose (RPTD), safety, preliminary antitumour activity and pharmacokinetics of intravenous aflibercept with irinotecan, 5-fluorouracil and leucovorin (LV5FU2). Patients
Autor:
J. Drabick, Mohammed M. Milhem, Nicholas N. Vahanian, Samir N. Khleif, Olivier Rixe, David H. Munn, Eugene P. Kennedy, Y. Zakharia, Charles J. Link
Publikováno v:
European Journal of Cancer. 51:S108
Autor:
Olivier Rixe, Thierry Petit, H. Bismuth, D. Nizri, D. Coeffic, G. Bastian, Ch. Borel, D. Khayat, M. Mahjoubi, C. Farabos, Gérard Auclerc, A. Benhammouda, D. Paraiso, F. Grossin, M. Weil, J. P. Grapin
Publikováno v:
European Journal of Cancer. 31:S198-S199
CPT-11, a DNA topoisomerase I inhibitor has been confirmed to demonstrate an anti-tumor effect specially against colorectal cancer (CRC). In order to define the best schedule combining the most two active agents in CRC, we initiated in June 94 a phas
Autor:
Remy Delva, Patrice Viens, Paul-Henri Cottu, P. Bougnoux, F. Burki, Olivier Rixe, A. Goupil, Thierry Petit, A. Laadem, J.M. Extra
Publikováno v:
European Journal of Cancer. 37:S323
Publikováno v:
European Journal of Cancer. 33:S249
Autor:
T. Tursz, Maud Brandely, C Toussaint, A Le Ceane, T. Le Chevalier, M. Spielmann, L. Kayitalire, Olivier Rixe, H Mezliai, P. Berthaud
Publikováno v:
European Journal of Cancer. 29:S47
Autor:
M. Weil, D. Khayat, Eric-Charles Antoine, L. Thill, Olivier Rixe, A. Benhammouda, E. Vuillemin, Jean-Marc Tourani, Ch. Borel, P. Banzet, Gérard Auclerc, C. Franks, C. Soubrane
Publikováno v:
European Journal of Cancer. 29:S179